Travatan Z
These highlights do not include all the information needed to use TRAVATAN Z safely and effectively. See full prescribing information for TRAVATAN Z. TRAVATAN Z (travoprost ophthalmic solution), for topical ophthalmic useInitial U.S. Approval: 2001
Approved
Approval ID
028455e0-ae77-4213-8819-3b58ef7d6a14
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 27, 2023
Manufacturers
FDA
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
travoprost
PRODUCT DETAILS
NDC Product Code0078-0946
Application NumberNDA021994
Marketing CategoryC73594
Route of AdministrationOPHTHALMIC
Effective DateJuly 12, 2022
Generic Nametravoprost
INGREDIENTS (9)
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRAVOPROSTActive
Quantity: 0.04 mg in 1 mL
Code: WJ68R08KX9
Classification: ACTIB
POLYOXYL 40 CASTOR OILInactive
Code: 4ERD2076EF
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ZINC CHLORIDEInactive
Code: 86Q357L16B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT